Thanks, Neil and Dave. Good morning, everyone. Starting with revenue. We generated revenue of $166.1 million, up 11% year-over-year and above the high end of our Q2 guidance range of $160 million to $162.5 million or up 7% to 9% year-over-year. From a channel perspective, retail revenue increased approximately 21.5% year-over-year while e-commerce revenue declined approximately 5.3% versus Q2 of 2022. For the second quarter, e-commerce represented 33% of our overall business compared to 39% in 2022 and in line with our pre-pandemic channel mix. The decline in e-commerce revenue was in line with our expectations and driven by an intentional reduction in marketing spend by 12% year-over-year, as we bring marketing spend as a percent of revenue back to pre-pandemic levels in the low teens. We expect e-commerce revenue to begin comping positive in H2 of this year, as we anniversary the pullbacks we've made in marketing spend and begin to increase marketing spend dollars year-over-year. We opened 13 new stores in Q2 and 39 over the past 12 months, finishing Q2 with 217 stores. Retail productivity in Q2 was 100% versus the same period last year. As a reminder, we define retail productivity as sales per average number of stores opened in the period. So even as we continue to add an average of 40 stores per year, our more mature cohorts continue to perform as those newer stores ramp. From a customer perspective, we finished the quarter with 2.28 million active customers an increase of 1.2% versus the same period a year ago and our average revenue per customer increased 9.2% year-over-year to $277. It's worth noting that our revenue growth by channel follows a similar pattern to our growth in active customers, where active customers are increasing in retail, driven by new store openings and decreasing in our e-commerce channel as we rebalance marketing spend. As Neil mentioned, we expect that active customer growth in Q2 will be our lowest for the year as we anniversary four consecutive quarters of marketing spend pullbacks and we're seeing positive momentum in Q3 already. We're pleased with our increase in average revenue per customer, which was primarily driven by a few factors including an increase in Progressives as a percentage of our business mix and continued ramping of both contact lens and eye exam sales. Progressives represented 23.2% of total prescription glasses sold in Q2 2023, up from 21.7%, when compared to the second quarter of 2022. This is still well below the market average of approximately 40%, leaving a substantial runway for product category growth. Progressives are also our highest gross margin and highest price point product starting at $295. We continue to make progress on our move into holistic vision care as we evolve from a glasses only brand into one that offers glasses, contacts and eye exams to customers. From Q2 2022 to Q2 2023 contact lenses have increased from 7% to 8.1% of our business mix. Over the same period eye care has increased from 2.4% to 3.9% of our business mix. Contacts and eye exams both represent large opportunities for future growth, each accounting for $10 billion plus portions of the $76 billion US optical industry. We remain well underpenetrated for sales of these products, as a percent of revenue versus other national optical retailers. Moving on to gross margin. As a reminder, our gross margin accounts for a range of costs including frames, lenses, optical labs, customer shipping optometrist salaries, store rent and the depreciation of store build-outs. Our gross margin also includes stock-based compensation expense for our optometrists and optical lab employees. For comparability, I will be speaking to gross margin excluding stock-based compensation. Second quarter adjusted gross margin was 54.7% compared to 55.2% in Q1 of this year and 57.9% in Q2 of last year. The year-over-year decrease, we saw was driven by strong growth of eye exams and contact lenses, as we evolve into a holistic vision care company and expand into these large segments of the optical industry. Eye exams and contacts have lower gross margin profiles than eyeglasses, but over the medium and long term are accretive to gross margin dollars and allow us to serve all of our customers' eye care needs. Expanding our contact offering is a core part of scaling our holistic vision care offering and a key driver of growing average revenue per customer. While contact lenses have a lower gross margin percentage compared to our other product offerings, their higher purchase frequency and subscription-like purchase cycle are accretive to gross margin dollars. We also experienced continued year-over-year gross margin deleverage in two areas that represent the more fixed portion of our cost of goods, retail occupancy and optometrist salaries, which are directly linked to our expansion into eye care. Our growth in store count has naturally led to an increase in store rent and depreciation from store build-outs. In Q2 specifically, we opened 13 new stores. We also saw downward pressure on gross margin year-over-year from an increase in overall optometry salaries, as we hired optometrists for our new stores, and continued the rollout of our Professional Corporation or PC model. As of the end of Q2 2023, we operated with 129 stores where we engage directly, with an optometrist and therefore, recognize both revenue from exams and optometrist salaries. This represents an increase of approximately 45% or 40 additional locations from 89 employed and PC exam stores at the end of the second quarter last year. We believe this ongoing investment in eye exam capabilities, will benefit the business long term as a result of greater control over the customer experience, new eye exam revenue and higher in-store conversion rates. There are a few accretive tailwinds to margin that act to partially offset these dilutive effects. First, we continue to scale our highest priced and highest gross margin Progressives business. In the second quarter, Progressives accounted for 23.2% of our prescription eyeglass units, which is up 150 basis points versus, a year ago. Secondly, we continue to scale the portion of prescription glasses orders that we in-sourced at our two owned optical labs in New York and Nevada. We expect our continued scaling at these facilities to result in continued gross margin benefits, along with higher Net Promoter Scores, lower refund rates and faster turnaround times. Shifting gears to SG&A. As a reminder, SG&A for our business includes three main components; salary expense covering our headquarters, customer experience, and retail employees; marketing spend including our home try-on program; and general corporate overhead expenses. Adjusted SG&A excludes non-cash costs like stock-based compensation expense, depreciation, and charitable equity donations. Adjusted SG&A in the second quarter was $86.8 million or 52.2% of revenue compared to Q2 2022 adjusted SG&A of $88.5 million or 59.2% of revenue. The primary drivers of the 700 basis point decrease in adjusted SG&A as a percentage of revenue were lower marketing costs and benefits from the adjustments to our cost structure we implemented in August of last year including lower salary and general corporate expenses. Marketing spend for the quarter came in at $18.2 million or 11% of revenue. This is down from $20.7 million and 13.8% of revenue in the same period last year. Marketing spend in Q2 2023 was 11.7% lower year-over-year which compares to revenue growth of up 11% year-over-year. Turning now to adjusted EBITDA. In the second quarter, we generated adjusted EBITDA of $14.2 million, representing an adjusted EBITDA margin of 8.5%, which compares to adjusted EBITDA of $5.9 million or 4% of revenue in the year ago period. This significant year-over-year improvement underscores our commitment and ability to drive profitable growth. Turning now to our balance sheet. We finished the quarter with a strong balance sheet position, reflecting $213 million in cash which we will continue to deploy deliberately to support our growth and operations. We also have an undrawn credit facility of $100 million other than $4 million for letters of credit that we can upsize to $175 million. Now, to our outlook. Based on our strong first half performance an updated view of the rest of 2023, we're raising the full year guidance we outlined in our Q4 earnings call in February and reaffirmed in our Q1 earnings call in May. For 2023, we now expect net revenue growth of approximately 9.5% to 11% representing a revenue range of $655 million to $664 million, adjusted EBITDA margin of approximately 7.9%, in line with prior guidance, which equates to adjusted EBITDA of approximately $52.1 million at the midpoint of our topline guidance range. We still expect gross margin in the mid-50s as a percent of revenue and to open 40 new stores this year. We're still forecasting stock-based compensation as a percentage of net revenue in 2023 to be roughly 10% compared with 16% in 2022. Stock-based compensation for both years is above our long-term forecast as a result of the multiyear equity grants to our co-CEOs in 2021. We still anticipate stock-based compensation to normalize to a range of 2% to 4% of net revenue late in 2024. With respect to the third quarter, we're guiding to the following; net revenue of $163 million to $165 million or revenue growth of approximately 9.5% to 11%. Through the first week of August, we've observed trailing 28-day retail productivity versus 2022 of 101%. From a bottom-line perspective, we're guiding to adjusted EBITDA of $8 million $9.5 million, representing an adjusted EBITDA margin of approximately 5% to 6%. With that, Neil, Dave and I, are pleased to take your questions. Operator, please open the line for Q&A.